Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LQDA | US
-1.93
-4.66%
Healthcare
Biotechnology
30/06/2024
17/04/2026
39.47
41.40
41.95
37.90
Liquidia Corporation a biopharmaceutical company develops manufactures and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. The company distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville North Carolina.
View LessPositive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
Weakness based on declining price with high volume
High Current Volume and Negative 1-Day Return
Midcap (2B - 10B USD)
High Short percentage (> 15%)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
52.7%1 month
50.1%3 months
61.0%6 months
63.6%-
-
15.42
0.05
0.02
-9.43
56.39
-
-95.84M
3.33B
3.33B
-
-743.29
-
-23.50
-181.73
11.41
21.63
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
5.36
Range1M
7.76
Range3M
17.55
Rel. volume
2.25
Price X volume
95.33M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Edgewise Therapeutics Inc. | EWTX | Biotechnology | 34.43 | 3.23B | 3.96% | n/a | 0.98% |
| Kiniksa Pharmaceuticals Ltd | KNSA | Biotechnology | 44.9 | 3.20B | -0.93% | n/a | 2.62% |
| NewAmsterdam Pharma Company N.V. Ordinary Shares | NAMS | Biotechnology | 34.68 | 3.12B | 4.46% | n/a | 0.15% |
| Travere Therapeutics Inc. | TVTX | Biotechnology | 40.77 | 3.12B | 3.11% | n/a | 2662.08% |
| Denali Therapeutics Inc | DNLI | Biotechnology | 20.57 | 2.94B | -0.68% | n/a | 3.51% |
| Spruce Biosciences Inc | SPRB | Biotechnology | 70.3 | 2.90B | 3.53% | n/a | 6.24% |
| Structure Therapeutics Inc. American Depositary Shares | GPCR | Biotechnology | 50.75 | 2.90B | -5.14% | n/a | 0.51% |
| ARCUTIS BIOTHERAPEUTICS INC. | ARQT | Biotechnology | 24.53 | 2.87B | 1.41% | n/a | 111.34% |
| IDEAYA Biosciences Inc | IDYA | Biotechnology | 33.91 | 2.86B | 4.31% | n/a | 0.20% |
| TNGX | TNGX | Biotechnology | 26.64 | 2.85B | 6.39% | n/a | 15.28% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| VeriFone Systems Inc | PAY | Building Products & Equipment | 28.59 | 3.56B | 2.18% | 102.46 | 2.10% |
| Polaris Industries Inc | PII | Recreational Vehicles | 57.91 | 3.23B | 9.22% | 14.48 | 170.51% |
| LCI Industries | LCII | Recreational Vehicles | 123.43 | 3.14B | 3.38% | 25.82 | 77.66% |
| Harley-Davidson Inc | HOG | Recreational Vehicles | 23.49 | 3.09B | 4.68% | 7.33 | 218.58% |
| Pitney Bowes Inc | PBI | Building Products & Equipment | 12.84 | 2.30B | 5.51% | n/a | -571.93% |
| HNI Corporation | HNI | Building Products & Equipment | 37.94 | 1.79B | 6.16% | 22.12 | 76.47% |
| ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 15.19 | 1.52B | 2.50% | n/a | 19.46% |
| Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 41.95 | 1.32B | 1.52% | 51.60 | 88.92% |
| Winnebago Industries Inc | WGO | Recreational Vehicles | 33.74 | 976.94M | 4.14% | 22.53 | 56.33% |
| Janus International Group Inc. | JBI | Building Products & Equipment | 5.54 | 805.08M | 5.73% | 11.62 | 116.21% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -9.43 | - | Cheaper |
| Ent. to Revenue | 56.39 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 15.42 | 15.55 | Par |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 60.96 | - | Par |
| Debt to Equity | 0.05 | -1.23 | Expensive |
| Debt to Assets | 0.02 | 0.25 | Cheaper |
| Market Cap | 3.33B | - | Par |